Buchsbaum D - Search Results

1

Monoclonal antibodies as potentiators of radiotherapy and chemotherapy in the management of head and neck cancer.

Wheeler RH, Spencer S, Buchsbaum D, Robert F. Wheeler RH, et al. Among authors: buchsbaum d. Curr Opin Oncol. 1999 May;11(3):187-90. doi: 10.1097/00001622-199905000-00009. Curr Opin Oncol. 1999. PMID: 10328593 Review.

2

Approaches to enhance cancer radiotherapy employing gene transfer methods.

Buchsbaum DJ, Raben D, Stackhouse MA, Khazaeli MB, Rogers BE, Rosenfeld ME, Liu T, Curiel DT. Buchsbaum DJ, et al. Gene Ther. 1996 Dec;3(12):1042-68. Gene Ther. 1996. PMID: 8986431 Review.

3

Targeting strategies for cancer radiotherapy.

Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT. Buchsbaum DJ, et al. Clin Cancer Res. 1999 Oct;5(10 Suppl):3048s-3055s. Clin Cancer Res. 1999. PMID: 10541342

4

Experimental radioimmunotherapy.

Buchsbaum DJ. Buchsbaum DJ. Semin Radiat Oncol. 2000 Apr;10(2):156-67. doi: 10.1016/s1053-4296(00)80052-1. Semin Radiat Oncol. 2000. PMID: 10727604 Review.

5

Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation.

Saleh MN, Raisch KP, Stackhouse MA, Grizzle WE, Bonner JA, Mayo MS, Kim HG, Meredith RF, Wheeler RH, Buchsbaum DJ. Saleh MN, et al. Among authors: buchsbaum dj. Cancer Biother Radiopharm. 1999 Dec;14(6):451-63. doi: 10.1089/cbr.1999.14.451. Cancer Biother Radiopharm. 1999. PMID: 10850332

6

Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers.

Bonner JA, Raisch KP, Trummell HQ, Robert F, Meredith RF, Spencer SA, Buchsbaum DJ, Saleh MN, Stackhouse MA, LoBuglio AF, Peters GE, Carroll WR, Waksal HW. Bonner JA, et al. Among authors: buchsbaum dj. J Clin Oncol. 2000 Nov 1;18(21 Suppl):47S-53S. J Clin Oncol. 2000. PMID: 11060327

7

Gene therapy for the treatment of cancer.

Buchsbaum DJ, Curiel DT. Buchsbaum DJ, et al. Cancer Biother Radiopharm. 2001 Aug;16(4):275-88. doi: 10.1089/108497801753131354. Cancer Biother Radiopharm. 2001. PMID: 11602998 Review.

8

Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation.

Buchsbaum DJ, Bonner JA, Grizzle WE, Stackhouse MA, Carpenter M, Hicklin DJ, Bohlen P, Raisch KP. Buchsbaum DJ, et al. Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1180-93. doi: 10.1016/s0360-3016(02)03788-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12419447

9

Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.

Buchsbaum DJ, Zhou T, Grizzle WE, Oliver PG, Hammond CJ, Zhang S, Carpenter M, LoBuglio AF. Buchsbaum DJ, et al. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3731-41. Clin Cancer Res. 2003. PMID: 14506165

10

Anti-EGFR-mediated radiosensitization as a result of augmented EGFR expression.

Bonner JA, Buchsbaum DJ, Russo SM, Fiveash JB, Trummell HQ, Curiel DT, Raisch KP. Bonner JA, et al. Int J Radiat Oncol Biol Phys. 2004;59(2 Suppl):2-10. doi: 10.1016/j.ijrobp.2004.01.053. Int J Radiat Oncol Biol Phys. 2004. PMID: 15142629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters